These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23709368)
1. Recent progress in prion and prion-like protein aggregation. Yi CW; Xu WC; Chen J; Liang Y Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):520-6. PubMed ID: 23709368 [TBL] [Abstract][Full Text] [Related]
2. The role of crowded physiological environments in prion and prion-like protein aggregation. Ma Q; Hu JY; Chen J; Liang Y Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393 [TBL] [Abstract][Full Text] [Related]
6. Prion and prion-like diseases in animals. Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937 [TBL] [Abstract][Full Text] [Related]
7. From molecule to molecule and cell to cell: prion-like mechanisms in amyotrophic lateral sclerosis. Grad LI; Fernando SM; Cashman NR Neurobiol Dis; 2015 May; 77():257-65. PubMed ID: 25701498 [TBL] [Abstract][Full Text] [Related]
8. Prion-like features of misfolded Aβ and tau aggregates. Morales R; Callegari K; Soto C Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736 [TBL] [Abstract][Full Text] [Related]
9. Prion encephalopathies of animals and humans. Prusiner SB Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114 [TBL] [Abstract][Full Text] [Related]
10. Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice. Stancu IC; Vasconcelos B; Ris L; Wang P; Villers A; Peeraer E; Buist A; Terwel D; Baatsen P; Oyelami T; Pierrot N; Casteels C; Bormans G; Kienlen-Campard P; Octave JN; Moechars D; Dewachter I Acta Neuropathol; 2015 Jun; 129(6):875-94. PubMed ID: 25862635 [TBL] [Abstract][Full Text] [Related]
11. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases. Ries HM; Nussbaum-Krammer C Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334 [TBL] [Abstract][Full Text] [Related]
12. Prion protein misfolding and disease. Moore RA; Taubner LM; Priola SA Curr Opin Struct Biol; 2009 Feb; 19(1):14-22. PubMed ID: 19157856 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins. Zhang J; Zhang Y J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221 [TBL] [Abstract][Full Text] [Related]
14. Aβ seeds and prions: How close the fit? Rasmussen J; Jucker M; Walker LC Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440 [TBL] [Abstract][Full Text] [Related]
15. Synthetic prions and other human neurodegenerative proteinopathies. Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570 [TBL] [Abstract][Full Text] [Related]
16. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases. Sarnataro D Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819 [TBL] [Abstract][Full Text] [Related]
17. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology. Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456 [TBL] [Abstract][Full Text] [Related]
18. Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation. Malinovska L; Palm S; Gibson K; Verbavatz JM; Alberti S Proc Natl Acad Sci U S A; 2015 May; 112(20):E2620-9. PubMed ID: 25941378 [TBL] [Abstract][Full Text] [Related]
19. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease. Jeffrey M Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056 [TBL] [Abstract][Full Text] [Related]